Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract The success of immunotherapy of cancer depends on several cellular events in the tumors that can be visualized by live microscopy strategies in experimental models. Taking advantage of advanced microscopy techniques, Lehmann and colleagues explore in this issue of CCR the mechanism of action of a novel bispecific mAb (TCB-CEA) that targets membrane-bound CEA and CD3ϵ. Clin Cancer Res; 22(17); 4277–9. ©2016 AACR. See related article by Lehmann et al., p. 4417

Original publication

DOI

10.1158/1078-0432.ccr-16-1072

Type

Journal article

Journal

Clinical Cancer Research

Publisher

American Association for Cancer Research (AACR)

Publication Date

01/09/2016

Volume

22

Pages

4277 - 4279